Clinical Trials Browser

Phase 1/2 × Recurrence × chiauranib × Clear all

NCT03166891 2020-01-18

Phase Ib Study of Chiauranib in Patients With Ovarian Cancer

Phase 1/2 Completed

Ovarian Neoplasms, Recurrence